Skip to main content
. Author manuscript; available in PMC: 2013 Feb 5.
Published in final edited form as: Transfusion. 2011 Nov 9;52(5):1117–1124. doi: 10.1111/j.1537-2995.2011.03428.x

TABLE 1.

Summary of findings

Molecular and serologic characterization Case 1 (HPA-22 [Sey]) Case 2 (HPA-23 [Hug])
Maternal serum versus healthy donor GPIIb/IIIa (HPA-1a/a, -3a/a)
    Flow cytometric analysis IgG−/IgM− IgG−/IgM−
    MACE (AP2 capture of GPIIb/IIIa)       −       −
Maternal serum versus healthy donor GPIIb/IIIa (HPA-1b/b, -2a/a, -3b/b, -5a/b, -15a/b)
    Flow cytometric analysis IgG−/IgM− IgG−/IgM−
    MACE (AP2 capture of GPIIb/IIIa)       −       −
Maternal serum versus paternal GPIIb/IIIa
    Flow cytometric analysis IgG+/IgM+ IgG+/IgM−
     (AP2 capture of GPIIb/IIIa)       −       −
    MACE (AP2 capture of GPIIb/IIIa)       +       +
Mother/Father blood type O/A1 O/A2B
    MACE reactivity after absorption of anti-A or anti-B       +       +
Molecular characterization
    Exon/nucleotide change 5/A584C 12/C1942T
    Amino acid change K164T R622W
    Protein GPIIb GPIIIa
    NCBI dsSNP accession number rs142811900 rs139166528
Maternal serum vs. recombinant GPIIb/IIIa mutated to express paternal SNP
    Flow cytometric analysis with transfected CHO cell lines       +       +
    MACE with mutated GPIIb/IIIa (AP2/Tab capture)       +       +